Sign in

CIK 0000805928

  • Large accelerated filer

Axogen, Inc.

Sign in to watch
Ticker
AXGN
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
MN
Entity type
Operating
EIN
411301878
Phone
+1 386-462-6817
Business address
13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615
Former names
LECTEC CORP /MN/
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market buy Director bought 10,000 shares at $6.56 ($65,600)
  3. 4 Open-market buy Director bought 10,000 shares at $6.11 ($61,100)
  4. 4 Option exercise Director acquired 6,459 shares (option exercise)
  5. 4 Option exercise Director acquired 6,459 shares (option exercise)
  6. 4 Option exercise Director acquired 6,459 shares (option exercise)
  7. 4 Open-market sale Director sold 41,980 shares at an average $8.71 ($365,780)
  8. 4 Option exercise Director acquired 6,459 shares (option exercise)
  9. 4 Option exercise Director acquired 6,459 shares (option exercise)
  10. 4 Open-market sale Director sold 7,468 shares at an average $9.23 ($68,899)
  11. 4 Option exercise Director acquired 28,750 shares (option exercise)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Shares withheld for taxes Chief Human Resources Officer gave up 4,270 shares (to pay taxes)
  14. 4 Shares withheld for taxes VP Operations gave up 2,769 shares (to pay taxes)
  15. 4 Shares withheld for taxes VP Peripheral Nerve Science gave up 2,769 shares (to pay taxes)
  16. 4 Option exercise CEO acquired 37,975 shares (option exercise)
  17. 4 Shares withheld for taxes General Counsel and CCO gave up 2,634 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief R&D Officer gave up 3,907 shares (to pay taxes)
  19. 4 Shares withheld for taxes EVP & Chief Financial Officer gave up 7,038 shares (to pay taxes)
  20. 4 Open-market sale EVP & Chief Financial Officer sold 42,981 shares at an average $9.53 ($409,680)

Page 8 of 36 · 705 filings